Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» transthyretin amyloidosis with cardiomyopathy
transthyretin amyloidosis with cardiomyopathy
Intellia Stumbles As It Aims For A First-Ever In CRISPR Gene Editing
Investors Business Daily
Thu, 10/19/23 - 10:12 am
Intellia
CRISPR
gene editing
transthyretin amyloidosis with cardiomyopathy
Alnylam’s Onpattro succeeds in open-label ATTR cardiomyopathy extension
Clinical Trials Arena
Mon, 05/22/23 - 10:11 am
Alnylam Pharmaceuticals
Onpattro
clinical trials
transthyretin amyloidosis with cardiomyopathy
Alnylam details anticipated results from heart disease drug trial
BioPharma Dive
Thu, 09/8/22 - 10:47 am
Alnylam
clinical trials
Onpattro
transthyretin amyloidosis with cardiomyopathy
